ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor concerns over Sanofi’s recent...
Search results for "drug treatment"
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to enter eight major markets in...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars
Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin...
"Punishment Alone Won't Stop the Express Train to Hell," Warns Addiction Expert Cheon Young-hoon
“A lot of people call drug addiction an ‘express train to hell,’ right. It is a remarkably accurate metaphor.
"A Bike Is More Thrilling Than a Syringe Now": Inside South Korea's Last-Resort Hospital Treating 90% of Hospitalized Drug Addicts
A 190-centimeter-tall man with celebrity-grade looks opened the examination room door and walked in.
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment
Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects
A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...